Navigation Links
Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
Date:5/11/2009

SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that Jay Hagan has joined the organization as Senior Vice President of Corporate Development and Strategy.

"Jay brings over 15 years of biotechnology operating and business development experience in a variety of roles including leadership of a significant number of important transactions. We are excited to add someone of Jay's breadth of experience to the Orexigen executive team, " said Michael Narachi, President and Chief Executive Officer. "His solid background will be invaluable as we focus on partnership opportunities and position the organization to successfully manage our operations, continue our development activities and execute on our commercialization plans for Contrave(R) and Empatic(TM)."

In his role, Jay will lead corporate development at Orexigen, notably focusing on partnership opportunities and commercialization strategy for lead products Contrave (naltrexone sustained release (SR)/bupropion SR), which is on track for an NDA submission to the FDA in the first half of 2010, and Empatic (zonisamide SR/bupropion SR), which is in the later stages of Phase 2 clinical development.

"I'm incredibly excited to join the Orexigen team at this pivotal time for the Company," said Jay. "Orexigen possesses a unique opportunity among small biotechnology companies. I look forward to leveraging my extensive experience in corporate and partnership strategy to further the Company's business development efforts."

Prior to joining Orexigen, Jay was a Partner at Groundswell Advisors, a biotechnology consulting firm, providing guidance and operational execution in corporate strategy, commercialization, financing and partnership op
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Orexigen(R) Therapeutics to Speak at Upcoming Conferences
2. Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results
3. Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
4. Orexigen(R) Therapeutics Schedules March 12, 2009 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2008
5. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
6. Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
7. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
8. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
9. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
10. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
11. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Supplementing their complete line ... for Eppendorf Safe Lock Centrifuge Tubes . ... highest quality tubes at an affordable price. Eppendorf ... doing chemical, medical, pharmaceutical, and life science research ... regularly able to afford Eppendorf products. , Eppendorf ...
(Date:8/27/2014)... California (PRWEB) August 27, 2014 ... (LLNL), through Lawrence Livermore National Security LLC ... to develop and deliver a state-of-the-art laser system ... facility (ELI Beamlines), under construction in the Czech ... performance, the laser system, called the " High ...
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Global Chelating Agents Market ... About Chelating Agent A chelating agent is ... with metal ions, thereby forming a metal-ion complex. ... have on chemical processes, formulations, and the environment ...
(Date:8/27/2014)... -- Guggenheim Securities, the investment banking and capital markets ... veteran equity analyst Charles "Tony" Butler as a managing ... on the biotech/biopharma sector. " Tony Butler ... a broad network of relationships in his industry," said ... of Equities at Guggenheim Securities. "His insights will further ...
Breaking Biology Technology:Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2
... FORT WORTH, Texas, April 14, 2011 The Wound ... forum on dynamic reciprocity at the combined meeting of ... Wound Healing Society (WHS) being held in Dallas at ... 14-17, 2011. Presenting faculty are Dr. Ira M. Herman, ...
... April 14, 2011 Reportlinker.com announces ... is available in its catalogue: ... And Biochips ... Product Development Opportunities and Business Expansion ...
... NEW YORK, April 14, 2011 Reportlinker.com ... is available in its catalogue: ... to 2017 – Neurostimulation Devices, Interventional Neurology ... China-to-2017-–-Neurostimulation-Devices-Interventional-Neurology-and-Other.html Neurology Devices Market Outlook ...
Cached Biology Technology:The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 2The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 3The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 4Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips 2Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips 3Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 2Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 3Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 4Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 5Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 6Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 7Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 8Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 9Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 10Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 11Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 12Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 13
(Date:8/27/2014)... Athens, Ga. An invasive grass species frequently found ... spiders, who then feed on American toads, a new ... which was accidentally introduced to the U.S. in the ... species and has spread to more than a dozen ... Typically found along roads and in forests, it can ...
(Date:8/27/2014)... When we want to listen carefully to someone, the ... thing we do is stop moving altogether. This strategy ... by our own movements. , This interplay between movement ... brain. Indeed, indirect evidence has long suggested that the ... auditory cortex, which gives rise to our conscious perception ...
(Date:8/27/2014)... described by the Volunteer Wildfire Services of South Africa ... government warned residents in certain parts of the province ... A high veld fire danger rating is expected ... the Great Kei and Mnquma area. Strong winds ... The thunderstorms bring lightning strikes and subsequent fire and ...
Breaking Biology News(10 mins):More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... Minnesotas Stem Cell Institute have described how an existing ... embryonic stem cells differentiate. The research appears in the ... Researchers know very little about how human embryonic stem ... renewal capacity and pluripotency, and their regulation, it is ...
... - Two carotid stenting trials examining patient outcomes ... by the American Heart Association (AHA) for patients ... these studies were presented today at the Cardiovascular ... scientific symposium by William A. Gray, M.D., FACC, ...
... LANSING, Mich. The computer program Captains Log ... hyperactivity disorder, brain injuries or learning disabilities ... are survivors of cerebral malaria. Michael Boivin, ... and ophthalmology and of psychiatry, and Bruno Giordani, ...
Cached Biology News:2 carotid artery stenting studies show results comparable to AHA guidelines 22 carotid artery stenting studies show results comparable to AHA guidelines 3MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria 2
Human CCL26/Eotaxin-3 MAb (Clone 115002)...
Normal sheep serum collected from healthy normal sheep...
Agarose-ME, 500 g. Suitable for immunoelectrophoresis.Gel point (1.5%): 36 1.5 C, EEO (-mr): 0.16-0.19, Gel strength (1%): > 1000 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Bio...
Pooled normal sreum with 0.1% sodium azide as preservative...
Biology Products: